Benchtop NIR method development for continuous manufacturing scale to enable efficient PAT application for solid oral dosage form

被引:19
|
作者
Alam, Md Anik [1 ]
Liu, Yang Angela [1 ]
Dolph, Stephanie [1 ]
Pawliczek, Marcin [2 ]
Peeters, Elisabeth [1 ]
Palm, Andrew [1 ]
机构
[1] Pfizer Inc, Worldwide Res & Dev, Groton, CT 06340 USA
[2] Pfizer Mfg Deutschland GmbH, Pfizer Global Supply, Freiburg, Germany
关键词
Process Analytical Technology; Near infrared; Continuous manufacturing; Direct compression; Potency monitoring; Calibration; Robustness; PROCESS ANALYTICAL TECHNOLOGY; NEAR-INFRARED SPECTROSCOPY; FEED FRAME; BLEND POTENCY; DRUG CONTENT;
D O I
10.1016/j.ijpharm.2021.120581
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A Near Infrared (NIR) method was developed using a small benchtop feed frame system to quantify Saccharin potency in a powder blend during continuous manufacturing process. A 15-point Design of Experiments (DoE) was created based on the NIR spectral response and compositions of the formulation to develop a calibration set. The calibration set was designed to create compositional and raw material lots variation using minimum resources. The calibration experiments utilized around 0.5 kg Saccharin (Active Pharmaceutical Ingredient (API) surrogate) and 1.8 kg of excipients. Partial Least Square (PLS) modeling was used to develop a quantitative NIR method from the calibration data. The NIR method was implemented during 5 test batches in two different manufacturing sites across different potency levels at a continuous manufacturing platform for direction compression. Acceptable prediction performance was achieved from the NIR method at both sites. The NIR method was robust against changes in process scale and NIR instruments. The variance information built into the calibration set was found to be critical to successful model performance. This study shows a benchtop feed frame can be used for material sparing calibration method development without operating at a full-scale process line and applied across multiple sites, instruments at different potency levels.
引用
收藏
页数:9
相关论文
共 11 条
  • [1] Application of continuous manufacturing for solid oral dosage forms
    Jung, Eun-A.
    Park, Young-Joon
    Kim, Joo-Eun
    JOURNAL OF PHARMACEUTICAL INVESTIGATION, 2023, 53 (04) : 457 - 474
  • [2] Application of continuous manufacturing for solid oral dosage forms
    Eun-A. Jung
    Young-Joon Park
    Joo-Eun Kim
    Journal of Pharmaceutical Investigation, 2023, 53 : 457 - 474
  • [3] The relevance of continuous solid oral dosage processing and NIR spectroscopy: In meeting the needs of QbD and PAT
    Chirkot, Thomas S.
    Pharmaceutical Technology, 2009, 33 (10) : 112 - 120
  • [4] Application of manufacturing Classification System to manufacturing method selection for oral solid dosage forms in Japan
    Suzuki, Hirofumi
    Takaishi, Yuuki
    Yoshimura, Motoyasu
    Hoshina, Wataru
    Shinogi, Yoshiaki
    Hisazumi, Jin
    Yamada, Azumi
    Sugie, Yutaka
    Aikawa, Shohei
    Yamada, Rie
    Quere, Jean-Philippe
    Mise, Ryohei
    Tahara, Kohei
    ADVANCED POWDER TECHNOLOGY, 2024, 35 (06)
  • [5] QbD-Driven Analytical Method Development and Validation for Raloxifene Hydrochloride in Pure Drug and Solid Oral Dosage Form
    Jain, Atul
    Sharma, Teenu
    Sharma, Gajanand
    Khurana, Rajneet Kaur
    Katare, Om Prakash
    Singh, Bhupinder
    ANALYTICAL CHEMISTRY LETTERS, 2019, 9 (04) : 463 - 477
  • [6] Development and Validation of RP-HPLC Method for Simultaneous Determination of Niacin (Extended Release) and Lovastatin in Oral Solid Dosage Form
    Devika, G. S.
    Sudhakar, M.
    Rao, J. Venkateshwara
    ORIENTAL JOURNAL OF CHEMISTRY, 2012, 28 (02) : 887 - 893
  • [7] Development and Validation of Stability-Indicating RP-HPLC Method for the Estimation of Lenalidomide and its Impurities in Oral Solid Dosage Form
    Prasad, Somana Siva
    Mohan, G. V. Krishna
    Babu, A. Naga
    ORIENTAL JOURNAL OF CHEMISTRY, 2019, 35 (01) : 140 - 149
  • [8] Rapid quantitative analysis of magnesium stearate in pharmaceutical powders and solid dosage forms by atomic absorption: Method development and application in product manufacturing
    Sugisawa, Keiichi
    Kaneko, Takashi
    Sago, Tsuyoshi
    Sato, Tomonobu
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2009, 49 (03) : 858 - 861
  • [9] Stability-indicating RP-HPLC method development and validation for the quantification of amlodipine besylate and valsartan tablets in solid oral dosage form
    Kamireddy, Teja
    Sambu, Pranitha
    Lankalapalli, Prasanna Kumar
    Myneni, Rama Krishna
    Divadari, Hareesh
    BIOMEDICAL CHROMATOGRAPHY, 2024, 38 (12)
  • [10] Development and Validation of a Stability-indicating RP-HPLC Method for Estimation of Metformin and Rosuvastatin along with Impurities from a Combined Oral Solid Dosage Form
    Sangeetha, D.
    Vadlamudi, M. K.
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 81 (02) : 365 - 372